This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Revaccination of pneumococcal vaccine

Authoring team

PCV13 and PCV15

  • a single priming dose of 0.5ml of PCV13 or PCV15 at 12 weeks of age
  • a booster dose of 0.5ml of PCV13 or PCV15 at one year of age (on or after their first birthday) given at the same time as the Hib/MenC, 4CMenB and MMR vaccines

PPV23

  • antibody levels are likely to decline rapidly in individuals with no spleen, splenic dysfunction or chronic renal disease - therefore re-immunisation with PPV23 is recommended every five years in these groups
  • revaccination is well tolerated
  • testing antibody levels prior to vaccination is not required
  • revaccination with PPV23 is currently not recommended for any other clinical risk groups or age groups.

Reference

  1. The Green Book. Chapter 25 - Pneumococcal (May 2025)

Related pages

Create an account to add page annotations

Create a free account

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page